- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-514619
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.51461
Zusammenfassung
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is an inherited orphan disease, in which the absence of capillary beds between arterioles and venules lead to arteriovenous shunts. Epistaxis is the core symptom. Several case reports have described the nonselective beta-adrenergic receptor antagonist timolol as a successful treatment method of nosebleeds due in HHT patients. OBJECTIVE: ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags